Fu et al. disclosed that RORα expression was downregulated in hepatocellular cancer (HCC) and concerned with serum AFP, pathology grade, tumor recurrence, invasion, and prognosis in HCC (10). The gene discussed is RORA; the disease is hepatocellular carcinoma.